The effects of intracellular and exosomal ncRNAs on cancer progression

Cancer Gene Ther. 2023 Dec;30(12):1587-1597. doi: 10.1038/s41417-023-00679-y. Epub 2023 Oct 26.

Abstract

Altered gene expression as well as mislocalization of a gene's encoded product (proteins or noncoding RNAs (ncRNAs)) can lead to disease and cancer formation. Multiple studies have indicated that exosomes and their contents act as cell-to-cell communicators and play a key role in cancer progression. Moreover, exosomes contain several functional molecules, including ncRNAs. NcRNAs function as master regulators to coordinate cell growth, cell motility and drug resistance. However, intracellular ncRNAs, which can be transferred to recipient cells via exosomes (exosomal ncRNAs), mediate common/distinct downstream molecules, signaling pathways and functions that are less emphasized concepts in cancer development research. In this study, by using exosomes as a model, we comprehensively discuss the current knowledge regarding (1) the functional role of ncRNAs, both their intracellular and exosomal forms, in cancer progression, (2) the possible mechanism of ncRNA incorporation into exosomes and (3) the therapeutic applications and limitations of exosomes based on current knowledge.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Exosomes* / genetics
  • Exosomes* / metabolism
  • Humans
  • Neoplasms* / genetics
  • Neoplasms* / metabolism
  • RNA, Untranslated / genetics
  • RNA, Untranslated / metabolism
  • Signal Transduction

Substances

  • RNA, Untranslated